Data / Form D filings / Nanomind, Inc.
Nanomind, Inc.: Form D filing
Nanomind, Inc., a biotechnology company in Stamford, CT, filed a Form D with the SEC in 2026. The latest, on June 22, 2026, reports $2 million sold of a $3 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 700 CANAL STREET 1ST FLOOR, Stamford, CT, 06902
- Phone
- (205) 797-1803
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2141439
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | New notice | $3,000,000 | $2,000,000 | $1,000,000 | 8 | May 1, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andres Torrubia | Executive Officer, Director | |
| Aurelia Bustos | Executive Officer, Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nanomind, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.